文献速递生殖医学

多囊卵巢综合征不良代谢表观遗传调控:白细胞PPARGC1A启动子甲基化的影响

Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter.
PubMed 文献 · Fertil Steril · 2016-11-23

横断面研究纳入175例多囊卵巢综合征(PCOS)女性和127例健康对照,在校正体质指数后,PCOS组白细胞PPARGC1A启动子甲基化特异性升高而线粒体DNA含量特异性降低;在代谢风险升高的PCOS女性中,上述差异进一步加剧。作者认为PPARGC1A启动子甲基化和线粒体含量可能是预测PCOS女性代谢风险的潜在生物标志物。

要点

  • PCOS女性白细胞PPARGC1A启动子甲基化较对照升高,线粒体DNA含量降低。
  • 代谢风险升高的PCOS女性中,上述甲基化升高和线粒体含量降低更明显。
  • 作者认为二者可能是预测PCOS代谢风险的潜在生物标志物。

核心结论

  • PPARGC1A启动子甲基化和线粒体含量可能是预测PCOS女性代谢风险的潜在生物标志物。

研究设计与样本

  • 横断面研究,纳入175例PCOS女性和127例健康对照,无干预。

主要发现

  • 校正体质指数后,PCOS组较对照组PPARGC1A启动子甲基化特异性升高、线粒体DNA含量特异性降低。
  • 在代谢风险升高的PCOS女性中,PPARGC1A启动子甲基化和线粒体含量的差异进一步加剧。

关键数值与推荐

  • 采用美国国家胆固醇教育计划成人治疗组第三次报告(ATPIII)的典型代谢风险标准对PCOS组和对照组进行分类。
  • PPARGC1A启动子甲基化采用甲基化特异性聚合酶链反应检测,线粒体DNA含量采用定量聚合酶链反应确认。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate PPARGC1A promoter methylation and mitochondria DNA (mtDNA) content in the leukocytes of women with polycystic ovary syndrome (PCOS) and analyze the relationship between these indices and metabolic risk for women with PCOS. DESIGN: Cross-sectional study. SETTING: University hospital. PATIENT(S): A total of 175 women with PCOS and 127 healthy controls. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Women with and without PCOS classified using the typical metabolic risk criteria of the National Cholesterol Education Program's Adult Treatment Panel III report (ATPIII), methylation of PPARGC1A promoter tested by methylation-specific polymerase chain reaction, and mtDNA content confirmed by quantitative polymerase chain reaction (PCR). RESULT(S): PPARGC1A promoter methylation was specifically increased, but mtDNA content was specifically decreased in women with PCOS compared with the control women after adjustment for body mass index. Moreover, in women with PCOS who have increased metabolic risk, the differences in PPARGC1A promoter methylation and mitochondrial content were aggravated. CONCLUSION(S): In conclusion, PPARGC1A promoter methylation and mitochondrial content were found to be potential biomarkers for the prediction of metabolic risk in women with PCOS.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Zhao H, Zhao Y, Ren Y, et al. Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter. Fertil Steril. 2016. PMID: 27889100. doi:10.1016/j.fertnstert.2016.10.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。